Luo, Tuoping; Masson, Kristina; Jaffe, Jacob D.; Silkworth, Whitney; Lee, Nathan Ross; Scherer, Christina A.; Scholl, Claudia; Fröhling, Stefan; Carr, Steven A.; Stern, Andrew M.; Schreiber, Stuart L.; Golub, Todd R.
(National Academy of Sciences, 2012-02)
Approximately 30% of human cancers harbor oncogenic gain-of-function mutations in KRAS. Despite interest in KRAS as a therapeutic target, direct blockade of KRAS function with small molecules has yet to be demonstrated. ...